Canada

Background: ProstaglandinE2 (PGE2) is a lipid signalling molecule involved in healthy neurodevelopment. Abnormal PGE2 levels due to genetic or environmental factors are linked to autism spectrum disorders (ASD). Our lab has shown that maternal PGE2 exposure results in differential developmental gene expression, and autism-like behaviours in offspring, including social deficits, and repetitive and anxious behaviours. Our goal was to examine the sex-dependent effect of prenatal PGE2 exposure on cerebellar dendritic morphology and related motor coordination. Methods: Cerebellums of PGE2 and Saline-injected C57BL/6 (WT) offspring at postnatal day 30 were stained with the GOLGI-COX method to measure dendrite length, branching, and the odds of observing dendritic loops. We also examined cerebellar-related motor function using adhesive sticker, grid walking, and cylinder tests. Results: PGE2 mice (males and females) had greater dendritic arborization closer to the soma and higher odds of observing dendritic loops than WT controls. Dendrite length was greater in WT Females (WTF) than in Males (WTM) with no significant differences observed in PGE2 Males (PGE2M) and Females (PGE2F). In the adhesive sticker test, we saw no significant differences in first sticker removal attempt times but more attempts per second in PGE2M. In the grid walking test, PGE2M slipped through the grid more than PGE2F, despite no WT sex differences. While WTM escaped faster than WTF, PGE2M escaped slower than PGE2F. In the cylinder test sex differences in rearing and wall touching in WT mice were lost in PGE2 mice. We saw a reduction in steps in PGE2M compared to WTM. We show that prenatal PGE2 signalling disruptions result in sex-dependent abnormalities in cerebellar development and behaviour.

CAN-ACN 2021

Prenatal PGE2 exposure causes abnormal cerebellar dendritic morphology and cerebellar related motor coordination in mice

motor coordination

prostaglandin e2

cerebellum

Colleagues and Friends:

I am very happy to welcome you to the 14th annual Canadian Neuroscience Meeting, and to the first virtual edition of our meeting. I want to highlight the important work the CAN meeting chair, **Roger Thompson** and co-chair, **Alyson Fournier**, did to put together the great program we are offering this year. Moving to a virtual format required a complete re-design of the program, and both Roger and Alyson did a splendid job in providing us with an appealing and well adapted program for our first virtual event. I wish to thank them for this very important effort.

Highlights of this year’s scientific meeting include invited speakers **Michael Hausser, Franck Polleux, Gwyneth Card, Magdalena Götz**and Brain Prize winner **Huda Zoghbi**. Plenary and parallel symposia, proposed by our members complete our diverse [scientific program.](https://can-acn.org/meeting-2021/program-2021/)

The 2021 Advocacy session, chaired and organized by CAN advocacy committee chair **Karun Singh**, will feature a special lecture and question period with Member of Parliament and past Science Minister **Kirsty Duncan**. This will be followed by a short overview of CAN’s advocacy activities over the last year. We invite you to participate in this session for insight from Dr. Duncan on the workings of Parliament Hill, and to learn more about what CAN has been doing to promote neuroscience research in Canada.

We are also excited to host **Lisa Willis** in the Equity Diversity and Inclusion session, organized by EDI committee chair **Jibran Khokhar**.

A special highlight of our meeting will be the lectures by award-winning young neuroscientists. We are please to host the CAN 2020 Young Investigator Award winner **Mihaela Iordanova**, and CAN 2021 Young Investigator Award winners **Aaron Phillips** and **Tabrez Siddiqui**. Highlights will also include presentation by the top three winners of the CAN-CIHR-INMHA Brain Star Award winners, **Claire Gizowski, Nuria Daviu Abant** and **Lukas Tamayo-Orrego**.

Independently organized satellite symposia complement and complete this exciting program, check them out here: https://can-acn.org/meeting-2021/2021-satellite-symposia/

Some of the most engaging sessions are always the poster sessions featuring the work of our trainees, so make sure to log in to Gather Town during the poster sessions to chat with the presenters.
We hope you enjoy this program, and look forward to welcoming you, virtually.

Shernaz Bamji

President of the Canadian Association for Neuroscience

![](https://assets.underline.io/uploads/markdown_image/1/image/b9aea25343a87d5aac3b9367dc780974.jpg)



Please head to https://can-acn.org/meeting-2021/registration-2021/ to register. 

14th Canadian Neuroscience Meeting from August 23rd-25th

poster

Cortical astrocytes are highly heterogeneous cells with distinct gene expression profiles, phenotypes, and functions. They are born from neural stem/progenitor cells (NSPCs) during embryonic development starting at E15 and undergo a period of rapid expansion in the first postnatal week. Whether time of astrocyte birth from NSPCs determines their position within the murine cerebral cortex is not known. To determine whether time of birth influences astrocyte distribution in the upper (UL) vs. lower (LL) cortical layers, we permanently labelled ventricular-subventricular zone (V-SVZ) NSPCs and their progeny via in utero electroporation with PiggyBac (PB)-CAG-EGFP at E15, 16, and 17 and sacrificed animals at P21. Immunohistochemistry (IHC) for the astrocyte lineage marker SOX9 was performed and EGFP+SOX9+ or EdU+SOX9+ astrocytes were quantified and compared between UL and LL cortical layers within each timepoint. PB-based labelling of EGFP+SOX9+ astrocytes showed that E15- and E16-born astrocytes were mostly found in the UL at P21; this bias was lost in E17-born astrocytes. As an alternative birth dating method, 5-ethynyl-2'deoxyuridine (EdU) was administered to pregnant mice at E16 and tissue was collected at P3 prior to astrocyte expansion. EdU labelling confirmed that SOX9+ astrocytes born at E16 were mostly found in the UL at P3. Altogether, our results suggest that the distribution of SOX9+ cortical astrocytes is influenced by birth date.

Cortical layer distribution of SOX9+ astrocytes from V-SVZ neural stem/progenitor cells depends on time of birth

Exposure to early life stress in humans and animals confers long-term consequences, affecting brain structure and function and increasing the risk for neuropsychiatric pathology. Early life stress can take different forms, such as parental loss, abuse, or poverty. The limited bedding (LB) paradigm has been used in animal models to simulate stress related to the lack of resources, affecting maternal care of her offspring. However, it is still unclear how the LB paradigm affects neonatal brain development, whether the reaching of specific neurodevelopmental milestones is modified differently in male and female offspring and whether a specific domain is preferentially affected. We examined daily reaching of physical, sensory, and motor milestones between P1-15 in offspring from LB and normal bedding (NB) mothers. We later tested open field locomotion and conditioned fear learning using the same animals as juveniles (P28). Animals subjected to the LB condition showed significant delays in achieving physical milestones, such as auditory canal opening; sensory milestones, such as ear twitching reflex and auditory startle response; and motor milestones, such as grasping reflex and surface righting reflex, compared to NB animals. Sex had no significant effect on some of these delays. At the juvenile stage, locomotor activity and conditioned fear response were comparable between groups and sex, suggesting that some of the maturational delays were compensated for after weaning for at least some behaviors. Supported by CIHR PJT162376 to CDW.

Early adversity modifies physical, sensory and motor neurodevelopmental milestones in rat pups

Aim: Youth nicotine exposure is a continued concern due to the growing use of electronic cigarettes and their largely unknown addiction liability, especially during vulnerable periods such as adolescence. Thus, the aim of the following research is to assess developmental differences in nicotine vapour-associated reward and withdrawal. Methods: Experiment 1 - adult and adolescent rats (n = 5-6/group) were exposed to either nicotine (JUUL, 5% nicotine) or vehicle (30:70 propylene glycol to glycerol) vapour using the open-source vapour exposure apparatus, OpenVape, for 10 minutes at 3 doses (2, 4, or 8 minutes of active vapour puffs). To evaluate the reward-like properties of nicotine, a biased place conditioning paradigm was implemented. Experiment 2 - adult and adolescent rats of both sexes (n = 7-8/group) were exposed to either JUUL or vehicle vapour for 10 minutes 3 times a day for 2 weeks. 16 hours following their final exposure, rats were injected with 1.5 mg/kg mecamylamine. 20 minutes following injections, rats were scored for somatic signs of withdrawal for a period of 10 minutes. Results: Experiment 1 - Two-Way ANOVA revealed a significant effect of age (F(1,45) = 9.872, p < 0.003) and dose (F (3,45) = 7.098 p < 0.001). Both adult and adolescent male rats showed significant increases in place preference for the nicotine-paired side, with adolescents displaying significant increases at lower doses than adults. Experiment 2 - Three-Way ANOVA revealed a significant effect of treatment (F(1,51) = 15.99, p < 0.0002) and Sex (F(1,51) = 15.91, p < 0.002) but not age (F(1,51) = 1.151, p = 0.2880). Conclusions: Our results support the notion that adolescence is a period that is more sensitive to the rewarding effects of, but not withdrawal from, nicotine.

Effects of nicotine vapour exposure on reward and withdrawal in adolescent and adult rats

Puberty is a critical period of sexual maturation that is vulnerable to the development of metabolic disorders. Metabolic disorders like Type-1 diabetes are more likely to develop in youths near the onset of puberty. Diabetes onset occurs later in boys than girls, mirroring average sex differences in pubertal onset. Attempts to control diabetic symptoms at their onset may improve prognosis and disease management. Lactate-producing probiotics improve glucose tolerance in adults, but it is unclear if this effect extends to pubertal individuals. Administration of lactate-producing probiotics may assist with glucose management at a vulnerable period of metabolic development. As of 5 weeks of age, 80 male and female CD-1 mice were given ad libitum access to either a control broth, or one of two probiotic solutions (Lacidofil or Cerebiome) for 14 days. Lacidofil and Cerebiome are proprietary blends of Lacticaseibacillus rhamnosus, Lactobacillus helveticus, and Bifidobacterium longum. Weight change and blood glucose and L-lactate concentrations were assessed with an oral glucose tolerance test prior to and after the probiotic treatment period. Pubertal male and female mice displayed less blood glucose, weight gain, and more blood L-lactate after Lacidofil treatment. Pubertal female mice displayed significantly less blood glucose, weight gain and more blood L-lactate after Cerebiome treatment. Our findings indicate that lactate-producing probiotics improve glucose tolerance in mice in a sex-specific manner and may assist in managing metabolic impairments consistent with diabetic development in pubertal groups.

Lactic-acid probiotics enhance glucose tolerance and weight gain in a pubertal mouse model

State-of-the-art imaging tools rely on a restrained preparation, limiting natural behavior while measuring cellular activity via fluorescence (FL). Recently, advances in wearable microscopy expanded the range of accessible behaviors by allowing imaging of freely behaving animals. However, wearable microscopes to this day are primarily used for brain imaging and have not been adopted for imaging other parts of the body, for example the spinal cord. Furthermore, unfavorable attributes of FL indicators constrain the extent of imaging experiments, including photobleaching, autofluorescence and excitation light scattering noise especially in the parts of the body like the spinal cord due to myelination. All 3 of these issues can be eliminated while offering an increase in the imaging depth by using bioluminescence (BL) instead of the FL. Here we demonstrate our ability of imaging BL calcium indicators through the cranial window in mice as fast as 5 frames per second using redesigned open-source miniscopes. Furthermore, we present an expansion of the miniscope use towards neurovascular imaging in the spinal cord. Spinal neurovascular imaging is accomplished by integrating a custom vertebral implant with miniscope hardware that ensures mechanical stability over time. Such implants allow interchangeable imaging of the brain or spinal cord in free or restrained animals. Altogether, our work expands the imaging toolbox towards better imaging quality via BL indicators and the ability to image across multiple sites throughout the nervous system using wearable miniature microscopes.

Next generation tools for imaging in the cortex and spinal cord

Researchers are expected to manage various responsibilities whilst staying up-to date with developments in their field. This is an arduous and time-consuming task. In Alzheimer's disease research alone, an average of 200 research articles are published every week. Last year we presented our podcast, AMiNDR, as a means of easing the burden on researchers. We offer an accessible audio format channel, sorting research into distinct categories and summarizing its contents. Each episode corresponds to a category or subtheme of research, complete with a bibliography of papers covered. In the year since its launch in June 2020, AMiNDR has published over 160 episodes with accompanying bibliographies. While the podcast has received positive feedback from researchers worldwide, we wonder if it is an effective way of disseminating knowledge and if it is achieving its goal of saving scientists time. To assess the podcast's reach, we tracked followers' growth and engagement across social media platforms and compared AMiNDR's performance with other prominent science communication podcasts with a similar target audience. We also measured the engagement with our podcast and website using Podcast Analytics and Google Analytics. respectively. We supplemented this with a survey to discern listeners' satisfaction with the service, followed-up with optional interviews for feedback. We present the results of this assessment with a list of recommendations for digital knowledge dissemination tools like the AMiNDR podcast. This will help further refine science communication initiatives in Neuroscience.

Are podcasts effective for knowledge dissemination to neuroscientists? Case study: AMiNDR podcast (a month in neurodegenerative disease research)

Recent optogenetic technologies have demonstrated not only light-dependent control of neuronal activity but also the regulation of target molecules by light, suggesting their potential applications to study cellular functions at the molecular level in the brain. Here, we introduce our optogenetic approaches for the non-invasive manipulation of intracellular cAMP processes with light in target neurons of the brain. cAMP is a ubiquitous secondary messenger for intracellular signalling pathways, mediating sensory transduction and neuromodulation. However, cAMP dynamics and related spatiotemporal functions remain elusive in the brain due to limitations of spatiotemporal specificity of pharmacological and genetic approaches to acutely perturb cAMP function. We have optimized and further established genetically encoded light-sensitive cAMP metabolic enzymes to enhance or suppress cAMP levels in living neurons. By expressing the light-sensitive cAMP metabolic enzymes with cAMP fluorescence indicators, we successfully monitored and manipulated cAMP levels of living hippocampal pyramidal neurons in murine hippocampal brain slices with two-photon laser microscopy, validating our optogenetic approaches in the target hippocampal neurons. Furthermore, we incorporated these optogenetic techniques directly in the target hippocampal neurons of freely behaving mice with brain-implanted fiber optic LED devices for light-dependent manipulation of cAMP in the intact brain. We will discuss in vivo optogenetic approaches in combination with murine hippocampus-dependent behavioural tests.

A toolbox for the optogenetic control of cAMP in vivo

The neurobiology of depression can increase the risk of developing Alzheimer disease (AD) in later life. The depression-related enzyme monoamine oxidase (MAO) has been implicated in the earliest lesions in the progression of AD. The two isoforms of MAO, e.g. MAO-A and MAO-B, catalyze the degradation of monoaminergic neurotransmitters (e.g. serotonin, dopamine, and noradrenaline) and MAO-mediated neurocytotoxicity may involve hydrogen peroxide (a reaction byproduct). MAO protein expression and catalytic activity often do not correlate and an unrecognized pool of inactive MAO could bias results and give rise to misleading conclusions. Perhaps this explains why MAO inhibition has been only modestly successful in clinical AD populations. It is impossible to differentiate active from inactive MAO protein in cells and tissues. Activity-based probes (ABPs) are probes designed to attach to the catalytic sites of active enzymes. Exploring this concept, our team has synthesized three fluorescent ABPs and using recombinant MAO-A and MAO-B proteins, endogenous (LnCAP cells) and overexpressed (N2a cells) MAO proteins, and confocal microscopy, we demonstrate that these probes bind irreversibly and selectively to MAO-A. This will benefit future live-cell imaging studies. ABPs, especially highly selective candidates, will give us a better understanding of the function of MAO-A and MAO-B in health and could help define a role for MAO in pathology and provide for a stage-specific therapeutic intervention strategy with benefit for clinical depression as well as AD.

Developing selective fluorophore-tagged activity-based probes for live-cell imaging of active monoamine oxidase

The resting perfusion of blood to the brain is immense and essential for proper function yet we have little understanding of how the brain regulates its basal blood supply. Astrocyte-mediated neurovascular coupling has conventionally been examined in the context of transient neuronally-evoked calcium (Ca2+) events triggering phasic changes in arteriole diameter to control blood flow. However, our group recently demonstrated that "resting" astrocyte Ca2+ levels control tonic, neural activity independent, brain blood flow. It was unclear if or how fluctuations in resting astrocyte Ca2+ regulated vascular tone in vivo. Using two-photon fluorescence imaging, astrocyte patch-clamp, pharmacology, chemogenetics and cre-lox gene knockdown in acute cortical brain slices and in vivo, we showed that increases in arteriole tone (vasoconstriction) caused a sustained elevation in the astrocyte endfoot Ca2+ level. Pharmacology suggested that a TRPV4-mediated Ca2+ influx initiated a Ca2+-dependent COX-1 pathway in endfeet that triggered the release of prostaglandin vasodilators. The role of endfoot COX-1 was further demonstrated with astrocyte specific cre-lox knockdown of the COX-1 gene PTGS1. Furthermore, chemogenetic control of arteriole constriction was sufficient to engage this pathway. While in brain slices this pathway appeared to be a static effect on arteriole tone, in awake mice in vivo, we found this pathway was involved in vasomotion - a pulsatile phenomenon of vascular contraction and relaxation occurring at ~0.1Hz which is important for the basal perfusion of tissue. Using an astrocyte selective AAV to overexpress a Ca2+ extrusion pump called CalEx, which clamps astrocyte free Ca2+ at a lower level and prevents increases, this largely abolished vasomotion compared to control virus. Our data demonstrated that bidirectional communication between astrocyte endfeet and arterioles is important for setting basal arteriole tone and vasomotion in vivo, which is likely an essential process for optimizing cerebral perfusion of oxygenated blood.

Bidirectional communication between astrocytes and arterioles controls vasomotion

BACKGROUND AND AIM Several functions, motor or sensory, rely on the ability of neurons to modify their discharge pattern to faithfully encode the characteristics of a sensory stimulus or to reflect a rhythmic motor control for example. Changes in firing pattern often involve particular ion channels and are intimately related to the function of the circuit. Astrocytes are increasingly recognized as key regulators of neural activity, through release of gliotransmitters. An increasing number of studies have documented how they affect synaptic and network functions. However, their contribution to neuronal computations is still poorly understood. METHODS: Whole cell patch recordings of neurons and astrocytes was combined to Ca2+-imaging and optogenetic manipulations in either brainstem or cortical slices from rats and transgenic mice. RESULTS: Here I will describe a mechanism first identified in a brainstem trigeminal circuit where neuronal firing pattern depends on particular Na+ channels sensitive to the extracellular Ca2 + concentration which is regulated by astrocytes through release of the calcium-binding protein, S100ß. The same mechanism also contribute to inputs integration and influences the input-output function of cortical layer 5 pyramidal neurons, and of primary afferents neurons. I will also describe how astrocytic coupling define functional domains and determines synchronization and coordination of neuronal firing within these domains. CONCLUSIONS Neuron-glia interactions are most often thought to occur at or near synapses. Our results suggest that astrocytes control neural activity by acting directly on or near the neuronal ionic channels, a largely unexplored form of communication between astrocytes and neurons. The S100β-dependent mechanism adds up to the previously reported conventional gliotransmitters such as glutamate, GABA, and ATP. Beyond increasing our understanding of how astrocytes contribute to neuronal computations an important value of our findings resides in the increased understanding of the role of S100β which is abnormally regulated after trauma and in many neurological disorders including epilepsy, depression, Parkinson's and Alzheimer's diseases. We propose that abnormal S100β control may have a wide impact by leading to abnormal extracellular ionic environment, abnormal neural activities, and thus pathological states.

Prenatal PGE2 exposure causes abnormal cerebellar dendritic morphology and cerebellar related motor coordination in mice

Next from CAN-ACN 2021

Cortical layer distribution of SOX9+ astrocytes from V-SVZ neural stem/progenitor cells depends on time of birth

Similar lecture

Endogenous cerebellin 1 prevents amyloid-β oligomers accumulation in the cerebellar granule cells

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES